top of page

Latest News

12/08/2025

iPETcertum-by-Claritas-Developed-with-Cutting-Edge-Technology-for-Enhancement-Automated-Segmentation-and-Accurate-Quantification-in-PET-PET-CT-MRI-Scans-Receives-FDA-Clearance.html

LONDON and NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art signal processing, quantification and AI technologies for the nuclear medicine industry, is pleased to announce that iPETcertumâ„¢, a software device for enhancement, automated segmentation and quantification in PET (Positron Emission Tomography) scans has received FDA clearance.

automated segmentation and accurate quantification of lesions by SUV and Volume

21/03/2023

Gadget review: release of new Airy Pods

This is placeholder text. To change this content, double-click on the element and click Change Content.

22/03/2023

Best smart wearables of 2023

This is placeholder text. To change this content, double-click on the element and click Change Content.

19/03/2023

How technology can help curb attention disorders

This is placeholder text. To change this content, double-click on the element and click Change Content.

18/03/2023

Entering a new era of IoT

This is placeholder text. To change this content, double-click on the element and click Change Content.

20/03/2023

Long-term benefits of clean energy sources

This is placeholder text. To change this content, double-click on the element and click Change Content.

© 2025 Powered by Claritas HealthTech Ltd.                                                                                                                                              Claritas NucMed Technologies Ltd. info@claritasco.com                                                                                                                                                                                       32 Cornhill, London EC3V3SG, UK

​

bottom of page